• Clinical trials of FemBloc, a novel non-surgical permanent birth control method, demonstrated 0% pregnancy rate among eligible participants, significantly outperforming the 6% benchmark for surgical sterilization.
• The innovative procedure, utilizing synthetic tissue adhesive for fallopian tube occlusion, reported no serious adverse events across 229 participants during five years of follow-up.
• Patient and practitioner satisfaction rates were notably high, positioning FemBloc as a promising alternative to traditional surgical sterilization methods.